Wednesday, December 09, 2015 4:59:51 PM
Don't worry about the partial clinical hold, or where they are going to find money to begin multiple trials for Direct, or how they will finish preparation of clinical sites, or how they will pay to complete the huge renovation of Swaston, or if they will be able to keep the lights on over the coming months.
I guess I;m a bit different. I don't "worry" about any of those issues. They are completely outside of my span of control. I believe Linda has done a pretty good job getting the company to this point despite all the shit thrown at her. I bet she is as surprised, as I am, that an anonymous report -- which states in the first page (1) its contents are not statements of fact but opinions and, (2) the author intends to profit from shorting the company's stock-- has gotten so much legitimacy and press time.
Ready, here's the point I think you are either missing or trivializing: NWBO has disruptive technology. The shorts, big-pharma, nay-sayers, etc really have a whole lot to loose if NWBO is successful. Additionally, Nowadays wall street everyday tactics are sophisticated, white-collar thuggery, plain and simple. In this environment, you don't know who your enemies are until your @zz has been eaten. Linda Powers must be ever so careful. I don't blame her for playing her cards so close to her vest and being careful about who she lets into NWBO's inner circle.
By the way, you have every right to have your views and express them when ever you want. If this was a close-to-perfect world and if the legal institutions, like the SEC, did their jobs, I would agree with a great deal of your concerns. However, I know these low-life Wall street wheelers and dealers can profit from fraudulent/theft activities against NWBO and by the time it takes the courts to address any wrong doing (if they do anything at all), Linda/NWBO will be dead, buried and sticking.
Linda needs to handle her business. I am not privy to the info/insight she has. I trust her to do the right thing (although I monitor her activities for validation). If I can't, I'll move my investment elsewhere.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
